Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Atomera Incorporated stock logo
ATOM
Atomera
$5.02
-3.3%
$5.72
$2.31
$17.55
$154.11M1.31491,110 shs4.20 million shs
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
$0.46
-10.1%
$0.41
$0.28
$3.60
$20.34M1.563.14 million shs5.18 million shs
Spok Holdings, Inc. stock logo
SPOK
Spok
$17.39
+0.2%
$16.25
$13.55
$17.96
$357.75M0.56119,510 shs379,114 shs
Yirendai Ltd. stock logo
YRD
Yirendai
$5.87
-1.0%
$6.37
$4.12
$9.20
$505.48M0.76148,623 shs53,173 shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Atomera Incorporated stock logo
ATOM
Atomera
0.00%+0.60%-18.51%+25.50%+31.76%
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
0.00%-13.49%-2.34%-18.73%-83.86%
Spok Holdings, Inc. stock logo
SPOK
Spok
0.00%+4.07%+6.75%+5.78%+17.42%
Yirendai Ltd. stock logo
YRD
Yirendai
0.00%-0.84%-6.45%-14.75%+29.58%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Atomera Incorporated stock logo
ATOM
Atomera
1.9044 of 5 stars
3.52.00.00.02.70.80.0
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
4.1961 of 5 stars
3.34.00.04.51.61.70.6
Spok Holdings, Inc. stock logo
SPOK
Spok
2.2767 of 5 stars
1.04.01.70.03.31.71.9
Yirendai Ltd. stock logo
YRD
Yirendai
3.0977 of 5 stars
0.05.02.50.01.11.71.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Atomera Incorporated stock logo
ATOM
Atomera
3.00
Buy$7.0039.44% Upside
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
2.50
Moderate Buy$3.00552.17% Upside
Spok Holdings, Inc. stock logo
SPOK
Spok
4.00
Strong Buy$20.0015.01% Upside
Yirendai Ltd. stock logo
YRD
Yirendai
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest HBIO, ATOM, SPOK, and YRD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/13/2025
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSpeculative Buy ➝ Speculative Buy$4.50 ➝ $3.00
5/1/2025
Spok Holdings, Inc. stock logo
SPOK
Spok
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
4/9/2025
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Sector Weight
(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Atomera Incorporated stock logo
ATOM
Atomera
$140K1,100.81N/AN/A$0.87 per share5.77
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
$94.14M0.22$0.10 per share4.59$1.45 per share0.32
Spok Holdings, Inc. stock logo
SPOK
Spok
$139.04M2.57$0.94 per share18.44$7.63 per share2.28
Yirendai Ltd. stock logo
YRD
Yirendai
$5.98B0.08$2.52 per share2.33$14.90 per share0.39
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Atomera Incorporated stock logo
ATOM
Atomera
-$18.43M-$0.66N/AN/A-15,555.37%-92.12%-77.31%7/29/2025 (Estimated)
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
-$12.40M-$1.32N/AN/A-63.51%-4.96%-2.24%8/14/2025 (Estimated)
Spok Holdings, Inc. stock logo
SPOK
Spok
$14.97M$0.7822.2922.01N/A11.45%10.26%7.45%7/23/2025 (Estimated)
Yirendai Ltd. stock logo
YRD
Yirendai
$216.77M$2.142.74N/A22.48%14.33%10.65%8/19/2025 (Estimated)

Latest HBIO, ATOM, SPOK, and YRD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/23/2025Q2 2025
Spok Holdings, Inc. stock logo
SPOK
Spok
$0.18N/AN/AN/A$35.00 millionN/A
6/12/2025Q1 2025
Yirendai Ltd. stock logo
YRD
Yirendai
N/A$0.39N/A$0.39N/A$214.22 million
5/6/2025Q1 2025
Atomera Incorporated stock logo
ATOM
Atomera
-$0.14-$0.17-$0.03-$0.17N/A$0.00 million
4/30/2025Q1 2025
Spok Holdings, Inc. stock logo
SPOK
Spok
$0.18$0.25+$0.07$0.25$34.00 million$36.29 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Atomera Incorporated stock logo
ATOM
Atomera
N/AN/AN/AN/AN/A
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
N/AN/AN/AN/AN/A
Spok Holdings, Inc. stock logo
SPOK
Spok
$1.257.19%N/A160.26%N/A
Yirendai Ltd. stock logo
YRD
Yirendai
$0.406.81%N/A18.69%N/A

Latest HBIO, ATOM, SPOK, and YRD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/30/2025
Spok Holdings, Inc. stock logo
SPOK
Spok
quarterly$0.31257.8%5/23/20255/23/20256/24/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Atomera Incorporated stock logo
ATOM
Atomera
N/A
8.59
8.59
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
N/A
0.81
0.40
Spok Holdings, Inc. stock logo
SPOK
Spok
N/A
1.24
1.24
Yirendai Ltd. stock logo
YRD
Yirendai
N/A
3.68
3.68

Institutional Ownership

CompanyInstitutional Ownership
Atomera Incorporated stock logo
ATOM
Atomera
30.79%
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
80.87%
Spok Holdings, Inc. stock logo
SPOK
Spok
50.81%
Yirendai Ltd. stock logo
YRD
Yirendai
1.99%

Insider Ownership

CompanyInsider Ownership
Atomera Incorporated stock logo
ATOM
Atomera
13.00%
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
9.50%
Spok Holdings, Inc. stock logo
SPOK
Spok
7.37%
Yirendai Ltd. stock logo
YRD
Yirendai
42.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
Atomera Incorporated stock logo
ATOM
Atomera
2030.70 million26.71 millionOptionable
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
49044.21 million40.01 millionOptionable
Spok Holdings, Inc. stock logo
SPOK
Spok
38020.57 million19.06 millionOptionable
Yirendai Ltd. stock logo
YRD
Yirendai
3,80086.41 million49.94 millionOptionable

Recent News About These Companies

Yiren Digital ADRs Decline After 1Q Profit Falls
Yiren Digital (NYSE:YRD) Issues Earnings Results

New MarketBeat Followers Over Time

Media Sentiment Over Time

Atomera stock logo

Atomera NASDAQ:ATOM

$5.02 -0.17 (-3.28%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$5.12 +0.11 (+2.09%)
As of 04:41 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Atomera Incorporated engages in the developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry in North America and the Asia Pacific. The company's lead technology is the Mears Silicon Technology, a thin film of reengineered silicon that can be applied as a transistor channel enhancement to CMOS-type transistors. Its customers include foundries, integrated device manufacturers, fabless semiconductor manufacturers, original equipment manufacturers, and electronic design automation companies. The company was formerly known as Mears Technologies, Inc. and changed its name to Atomera Incorporated in January 2016. Atomera Incorporated was founded in 2001 and is headquartered in Los Gatos, California.

Harvard Bioscience stock logo

Harvard Bioscience NASDAQ:HBIO

$0.46 -0.05 (-10.14%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$0.50 +0.04 (+9.35%)
As of 05:15 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It also provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through sales organizations, websites, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic labs. It primarily sells its products under Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.

Spok stock logo

Spok NASDAQ:SPOK

$17.39 +0.03 (+0.17%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$15.52 -1.87 (-10.72%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Spok Holdings, Inc., through its subsidiary, Spok, Inc., provides healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. The company's products and services enhance workflows for clinicians and support administrative compliance. It delivers clinical information to care teams when and where it matters to enhance patient outcomes; and provides GenA Pager, a one-way alphanumeric pager. The company offers subscriptions to one-way or two-way messaging services, as well as alphanumeric pagers that are configurable to support unencrypted or encrypted operation; and ancillary services, such as voicemail, and equipment loss or maintenance protection services, as well as sells devices to resellers who lease or resell them to their subscribers. Its Spok Care Connect suite products for contact centers, clinical alerting and notification, mobile communications and messaging, and public safety notifications. In addition, the company provides professional, software license updates, and product support services, as well as sells third-party equipment. It serves businesses, professionals, management personnel, medical personnel, field sales personnel and service forces, members of the construction industry and construction trades, real estate brokers and developers, sales and services organizations, specialty trade organizations, manufacturing organizations, and government agencies. The company was formerly known as USA Mobility, Inc. and changed its name to Spok Holdings, Inc. in July 2014. Spok Holdings, Inc. was founded in 1986 and is headquartered in Alexandria, Virginia.

Yirendai stock logo

Yirendai NYSE:YRD

$5.87 -0.06 (-1.01%)
Closing price 06/27/2025 03:58 PM Eastern
Extended Trading
$5.70 -0.17 (-2.90%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Yiren Digital Ltd. provides financial services through an AI-powered platform in China. Its platform provides a suite of financial and lifestyle services. The company offers financial services, which provides a portfolio of loan products to borrowers; insurance brokerage services; and consumption and lifestyle services, including non-financial products and services to meet various consumer needs. It supports clients at various growth stages, addressing financing needs arising from consumption and production activities, and augmenting the well-being and security of individuals, families, and businesses. The company was formerly known as Yirendai Ltd. and changed its name to Yiren Digital Ltd. in September 2019. Yiren Digital Ltd. was founded in 2012 and is based in Beijing, the People's Republic of China. Yiren Digital Ltd. operates as a subsidiary of CreditEase Holdings (Cayman) Limited.